1. Home
  2. NUAI vs IMCC Comparison

NUAI vs IMCC Comparison

Compare NUAI & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUAI
  • IMCC
  • Stock Information
  • Founded
  • NUAI N/A
  • IMCC 1980
  • Country
  • NUAI United States
  • IMCC Israel
  • Employees
  • NUAI N/A
  • IMCC N/A
  • Industry
  • NUAI Oil & Gas Production
  • IMCC Medicinal Chemicals and Botanical Products
  • Sector
  • NUAI Energy
  • IMCC Health Care
  • Exchange
  • NUAI Nasdaq
  • IMCC Nasdaq
  • Market Cap
  • NUAI 11.3M
  • IMCC 12.2M
  • IPO Year
  • NUAI N/A
  • IMCC N/A
  • Fundamental
  • Price
  • NUAI $0.40
  • IMCC $1.97
  • Analyst Decision
  • NUAI
  • IMCC
  • Analyst Count
  • NUAI 0
  • IMCC 0
  • Target Price
  • NUAI N/A
  • IMCC N/A
  • AVG Volume (30 Days)
  • NUAI 7.1M
  • IMCC 70.5K
  • Earning Date
  • NUAI 08-14-2025
  • IMCC 08-12-2025
  • Dividend Yield
  • NUAI N/A
  • IMCC N/A
  • EPS Growth
  • NUAI N/A
  • IMCC N/A
  • EPS
  • NUAI N/A
  • IMCC N/A
  • Revenue
  • NUAI $718,761.00
  • IMCC $38,430,631.00
  • Revenue This Year
  • NUAI N/A
  • IMCC $47.12
  • Revenue Next Year
  • NUAI N/A
  • IMCC $12.83
  • P/E Ratio
  • NUAI N/A
  • IMCC N/A
  • Revenue Growth
  • NUAI 14.80
  • IMCC 5.08
  • 52 Week Low
  • NUAI $0.32
  • IMCC $1.29
  • 52 Week High
  • NUAI $12.29
  • IMCC $7.12
  • Technical
  • Relative Strength Index (RSI)
  • NUAI N/A
  • IMCC 39.04
  • Support Level
  • NUAI N/A
  • IMCC $1.74
  • Resistance Level
  • NUAI N/A
  • IMCC $2.03
  • Average True Range (ATR)
  • NUAI 0.00
  • IMCC 0.26
  • MACD
  • NUAI 0.00
  • IMCC -0.01
  • Stochastic Oscillator
  • NUAI 0.00
  • IMCC 43.29

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Share on Social Networks: